Skip to main content


Health

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.
556 of 1543




Newsletter Sign Up

Daily Readings

Reading 1, First Corinthians 2:1-5
Now when I came to you, brothers, I did not come with any ... Read More

Psalm, Psalms 119:97, 98, 99, 100, 101, 102
How I love your Law! I ponder it all day long. You make me ... Read More

Gospel, Luke 4:16-30
He came to Nazara, where he had been brought up, and went into ... Read More

Saint of the Day

September 1 Saint of the Day

St. Giles, Abbot
September 1: St. Giles, Abbot (Patron of Physically Disabled) Feast day - ... Read More